News Release

June 21, 2017 at 8:30 AM EDT

Regeneron Recognized on "The Civic 50" List of the Most Community-Minded Companies in the United States

TARRYTOWN, N.Y., June 21, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the company was included on The Civic 50, a recognition granted to the most community-minded companies in the United States by Points of Light, the world's largest organization dedicated to volunteer service.


Regeneron makes its debut to The Civic 50 alongside public and private companies that were surveyed and selected based on four dimensions of community engagement programs: investment, integration, institutionalization and impact. The Civic 50 provides a national standard for superior corporate citizenship and showcases how companies can use their time, skills and other resources to improve the quality of life in the communities where they do business.

"We are honored to be added to The Civic 50, which celebrates the longstanding commitment the people of Regeneron have to giving back," said Hala Mirza, Vice President, Corporate Communications and Citizenship at Regeneron. "Our citizenship programs take many shapes, but share a focus on driving meaningful change for important communities. We nurture the development of talented young scientists through major programs such as the Regeneron Science Talent Search for high school students and also support our local communities by providing crucial services for those in need."

Regeneron's citizenship and community involvement programs include the title sponsorship of the Science Talent Search, the nation's most prestigious science and math competition for high school seniors, for which Regeneron has pledged $100 million over 10 years. Regeneron also supports many local and national initiatives for Science, Technology, Engineering and Math (STEM) education, with a commitment to supporting top student talent, diversifying the talent pool and increasing access to STEM education for underrepresented populations. Beyond STEM, Regeneron empowers employees to give back through Regeneron in the Community, a program including more than 1,200 volunteers supporting 650 organizations.

The Civic 50 winners were announced on June 20 at the Points of Light Conference on Volunteering and Service in Seattle, Washington. To learn more about The Civic 50, visit

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to consistently translate science into medicine has led to six FDA-approved treatments and over a dozen product candidates, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, heart disease, allergic and inflammatory diseases, pain, cancer, infectious diseases and rare diseases.

Regeneron is accelerating and improving the traditional drug development process through its proprietary VelociSuite® technologies, including VelocImmune® which yields optimized fully-human antibodies, and ambitious initiatives such as the Regeneron Genetics Center, one of the largest genetics sequencing efforts in the world. For additional information about the company, please visit or follow @Regeneron on Twitter.

 Regeneron Contacts:

Media Relations

Alexandra Bowie

Tel.: +1 (914) 847-3407

Investor Relations

Manisha Narasimhan, Ph.D.

Tel.: +1 (914) 847-5126



To view the original version on PR Newswire, visit:

SOURCE Regeneron Pharmaceuticals, Inc.



News Provided by Acquire Media